Pathogenesis and host control of gammaherpesviruses: Lessons from the mouse

Annual Review of Immunology

Volumn 29, Issue , 2011, Pages 351-397

  Barton, Erik ^a   Mandal, Pratyusha ^a   Speck, Samuel H ^b  

^a PURDUE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic infection; interferons; latency; lymphoma; reactivation

Indexed keywords

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; EPSTEIN BARR VIRUS; GAMMAHERPESVIRINAE; HUMAN; IMMUNE RESPONSE; KAPOSI SARCOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS LATENCY;

ANIMALS; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; HOST SPECIFICITY; HUMANS; MICE; TUMOR VIRUS INFECTIONS;

EID: 79953048485     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-072710-081639     Document Type: Article

References (239)

1. McGeoch DJ, Rixon FJ, Davison AJ. 2006. Topics in herpesvirus genomics and evolution. Virus Res. 117:90-104.
2. Arbuckle JH, Medveczky MM, Luka J, Hadley SH, Luegmayr A, et al. 2010. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc. Natl. Acad. Sci. USA 107:5563-68.
3. Lacoste V, Lavergne A, de Thoisy B, Pouliquen JF, Gessain A. 2010. Genetic diversity and molecular evolution of human and non-human primate Gammaherpesvirinae. Infect. Genet. Evol. 10:1-13.
4. Rowe M, Kelly GL, Bell AI, Rickinson AB. 2009. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin. Cancer Biol. 19:377-88.
5. Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G. 1967. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064-65.
6. Bornkamm GW, Hammerschmidt W. 2001. Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. Ser. B 356:437-59. (Pubitemid 32442745)
7. Farrell PJ. 1998. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 6:175-77;discussion 177-78. (Pubitemid 28259582)
8. Klein E, Teramoto N, Gogolak P, Nagy N, Bjorkholm M. 1999. LMP-1, the Epstein-Barr virusencoded oncogene with a B cell activating mechanism similar to CD40. Immunol. Lett. 68:147-54. (Pubitemid 29265666)
9. Hayward SD, Liu J, FujimuroM. 2006. Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses. Science STKE 2006:re4.
10. Hayward SD. 2004. Viral interactions with the Notch pathway. Semin. Cancer Biol. 14:387-96. (Pubitemid 38993640)
11. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκrecombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-72.
12. Henkel T, Ling PD, Hayward SD, Peterson MG. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265:92-95.
13. Waltzer L, Bourillot PY, Sergeant A, Manet E. 1995. RBP- Jκrepression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2. Nucleic Acids Res. 23:4939-45.
14. Zimber-Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, et al. 1994. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila Suppressor of Hairless. EMBO J. 13:4973-82.
15. Bain M, Watson RJ, Farrell PJ, Allday MJ. 1996. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J. Virol. 70:2481-89.
16. Johannsen E, MillerCL, Grossman SR, KieffE. 1996. EBNA-2 andEBNA-3C extensively and mutually exclusively associate with RBPJκin Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70:4179-83.
17. Radkov SA, Bain M, Farrell PJ, West M, Rowe M, Allday MJ. 1997. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J. Virol. 71:8552-62. (Pubitemid 27446437)
18. Radkov SA, Touitou R, Brehm A, Rowe M, West M, et al. 1999. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73:5688-97. (Pubitemid 29274854)
19. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, et al. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ. J. Virol. 69:3108-16.
20. Yates J, Warren N, Reisman D, Sugden B. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-10. (Pubitemid 14087807)
21. Yates JL, Warren N, Sugden B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-15. (Pubitemid 15130835)
22. Reisman D, Yates J, Sugden B. 1985. A putative origin of replication of plasmids derived from Epstein- Barr virus is composed of two cis-acting components. Mol. Cell Biol. 5:1822-32. (Pubitemid 15049139)
23. Rickinson AB, Kieff E. 2007. Epstein-Barr virus. In Fields Virology, ed. DM Knipe, PM Howley, pp. 2655-700. Philadelphia: Wolters Kluwer/Lippincott, Williams &Wilkins.
24. Thorley-Lawson DA. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82. (Pubitemid 33741978)
25. Bhende PM, Dickerson SJ, Sun X, Feng WH, Kenney SC. 2007. X-box-binding protein 1 activates lytic Epstein-Barr virus gene expression in combination with protein kinase D. J. Virol. 81:7363-70. (Pubitemid 47047825)
26. Laichalk LL, Thorley-Lawson DA. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 79:1296-307. (Pubitemid 40053911)
27. Sun CC, Thorley-Lawson DA. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81:13566-77. (Pubitemid 350247850)
28. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-69.
29. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, et al. 1996. Kaposi's sarcoma-associated herpesvirus containsGprotein-coupled receptor and cyclinDhomologs which are expressed inKaposi's sarcoma and malignant lymphoma. J. Virol. 70:8218-23. (Pubitemid 26339142)
30. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, et al. 1995. Kaposi's sarcomaassociated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-80.
31. Trimble JJ, Desrosiers RC. 1991. Transformation by herpesvirus saimiri. Adv. Cancer Res. 56:335-55.
32. Falk L, Wright J, Wolfe L, Deinhardt F. 1974. Herpesvirus ateles: transformation in vitro of marmoset splenic lymphocytes. Int. J. Cancer 14:244-51.
33. Damania B, Choi JK, Jung JU. 2000. Signaling activities of gammaherpesvirus membrane proteins. J. Virol. 74:1593-601. (Pubitemid 30434014)
34. Wen KW, Damania B. 2010. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 289:140-50.
35. Speck SH, Ganem D. 2010. Viral latency and its regulation: lessons from the γ-herpesviruses. Cell Host Microbe 8:100-15.
36. Blaskovic D, Stancekova M, Svobodova J, Mistrikova J. 1980. Isolation of five strains of herpesviruses from two species of free living small rodents. Acta Virol. 24:468.
37. Chastel C, Beaucournu JP, Chastel O, LegrandMC, Le Goff F. 1994. A herpesvirus from an European shrew (Crocidura russula). Acta Virol. 38:309.
38. Hughes DJ, Kipar A, Milligan SG, Cunningham C, Sanders M, et al. 2010. Characterization of a novel wood mouse virus related to murid herpesvirus 4. J. Gen. Virol. 91:867-79.
39. Blasdell K, McCracken C, Morris A, Nash AA, Begon M, et al. 2003. The wood mouse is a natural host for Murid herpesvirus 4. J. Gen. Virol. 84:111-13. (Pubitemid 36113555)
40. Nash AA, Dutia BM, Stewart JP, Davison AJ. 2001. Natural history of murine γ-herpesvirus infection. Philos. Trans. R. Soc. Lond. Ser. B 356:569-79. (Pubitemid 32442753)
41. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA. 1992. Virological and pathological features of mice infected with murine γ-herpesvirus 68. J. Gen. Virol. 73(Pt. 9):2347-56.
42. Usherwood EJ, Stewart JP, Robertson K, Allen DJ, Nash AA. 1996. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77(Pt. 11):2819-25. (Pubitemid 26390583)
43. Weck KE, Kim SS, Virgin HW 4th, Speck SH. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651-61. (Pubitemid 29246723)
44. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HW 4th. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70:6775-80. (Pubitemid 26307385)
45. Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, et al. 1997. Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γresponsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-53. (Pubitemid 28011034)
46. McGeoch DJ, Gatherer D, Dolan A. 2005. On phylogenetic relationships among major lineages of the Gammaherpesvirinae. J. Gen. Virol. 86:307-16. (Pubitemid 40227941)
47. Virgin HW4th, Latreille P, Wamsley P, Hallsworth K, Weck KE, et al. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-904. (Pubitemid 27304926)
48. MoormanNJ, LinCY, Speck SH. 2004. Identification of candidate gammaherpesvirus 68 genes required for virus replication by signature-tagged transposon mutagenesis. J. Virol. 78:10282-90. (Pubitemid 39258353)
49. Song MJ, Hwang S, Wong WH, Wu TT, Lee S, et al. 2005. Identification of viral genes essential for replication of murine γ-herpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. USA 102:3805-10. (Pubitemid 40354693)
50. Sunil-Chandra NP, Efstathiou S, Nash AA. 1993. Interactions of murine gammaherpesvirus 68 with B and T cell lines. Virology 193:825-33.
51. Weck KE, Kim SS, Virgin HW 4th, Speck SH. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73:3273-83. (Pubitemid 29135720)
52. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. 2000. Latent murine γ-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165:1074-81. (Pubitemid 30484779)
53. Sunil-Chandra NP, Efstathiou S, Nash AA. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73(Pt. 12):3275-79. (Pubitemid 23014183)
54. Moser JM, Upton JW, Gray KS, Speck SH. 2005. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency. J. Virol. 79:5227-31. (Pubitemid 40464272)
55. Gargano LM, Forrest JC, Speck SH. 2009. Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo. J. Virol. 83:1474-82.
56. Tibbetts SA, Loh J, Van Berkel V, McClellan JS, Jacoby MA, et al. 2003. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77:7696-701. (Pubitemid 36734542)
57. Thorley-Lawson DA, Duca KA, Shapiro M. 2008. Epstein-Barr virus: a paradigm for persistent infection-for real and in virtual reality. Trends Immunol. 29:195-201.
58. Flano E, Kim IJ, Woodland DL, Blackman MA. 2002. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J. Exp. Med. 196:1363-72. (Pubitemid 35375555)
59. Willer DO, Speck SH. 2003. Long-term latentmurineGammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J. Virol. 77:8310-21. (Pubitemid 36871459)
60. Moorman NJ, Willer DO, Speck SH. 2003. The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J. Virol. 77:10295-303. (Pubitemid 37129673)
61. Fowler P, Marques S, Simas JP, Efstathiou S. 2003. ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J. Gen. Virol. 84:3405-16. (Pubitemid 37540768)
62. Paden CR, Forrest JC, MoormanNJ, Speck SH. 2010. Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J. Virol. 84:7214-24.
63. Forrest JC, Paden CR, AllenRD3rd, Collins J, Speck SH. 2007. ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication. J. Virol. 81:11957-71. (Pubitemid 47623827)
64. Li Q, Zhou F, Ye F, Gao SJ. 2008. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 379:234-44.
65. Wen KW, Dittmer DP, Damania B. 2009. Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. J. Virol. 83:9786-802.
66. van Dyk LF, Hess JL, Katz JD, Jacoby M, Speck SH, Virgin HW 4th. 1999. The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes. J. Virol. 73:5110-22. (Pubitemid 29246773)
67. Card GL, Knowles P, Laman H, Jones N, McDonald NQ. 2000. Crystal structure of a γ-herpesvirus cyclin-cdk complex. EMBO J. 19:2877-88. (Pubitemid 30386760)
68. Swanton C, Card GL, Mann D, McDonald N, Jones N. 1999. Overcoming inhibitions: subversion of CKI function by viral cyclins. Trends Biochem. Sci. 24:116-20. (Pubitemid 29225246)
69. Allen RD 3rd, Dickerson S, Speck SH. 2006. Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection. J. Virol. 80:2055-62. (Pubitemid 43228746)
70. Coleman HM, Efstathiou S, Stevenson PG. 2005. Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J. Gen. Virol. 86:561-74. (Pubitemid 40331235)
71. van Dyk LF, Virgin HW4th, Speck SH. 2000. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Virol. 74:7451-61. (Pubitemid 30613090)
72. Hoge AT, Hendrickson SB, Burns WH. 2000. Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J. Virol. 74:7016-23. (Pubitemid 30470684)
73. Upton JW, Speck SH. 2006. Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin. J. Virol. 80:11946-59. (Pubitemid 44904344)
74. WakelingMN, Roy DJ, Nash AA, Stewart JP. 2001. Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. J. Gen. Virol. 82:1187-97. (Pubitemid 32454619)
75. MoormanNJ, VirginHW4th, Speck SH. 2003. Disruption of the gene encoding the γHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307:179-90. (Pubitemid 36344154)
76. Lee BJ, KoszinowskiUH, Sarawar SR, AdlerH. 2003. A gammaherpesvirusGprotein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J. Immunol. 170:243-51. (Pubitemid 36026146)
77. Verzijl D, Fitzsimons CP, Van Dijk M, Stewart JP, Timmerman H, et al. 2004. Differential activation of murine herpesvirus 68- and Kaposi's sarcoma-associated herpesvirus-encoded ORF74 G proteincoupled receptors by human and murine chemokines. J. Virol. 78:3343-51. (Pubitemid 38568275)
78. Wang GH, Garvey TL, Cohen JI. 1999. The murine gammaherpesvirus-68 M11 protein inhibits Fasand TNF-induced apoptosis. J. Gen. Virol. 80(Pt. 10):2737-40. (Pubitemid 29458636)
79. Roy DJ, Ebrahimi BC, Dutia BM, Nash AA, Stewart JP. 2000. Murine gammaherpesvirus M11 gene product inhibits apoptosis and is expressed during virus persistence. Arch. Virol. 145:2411-20. (Pubitemid 32040098)
80. Loh J, Huang Q, Petros AM, Nettesheim D, van Dyk LF, et al. 2005. A surface groove essential for viral Bcl-2 function during chronic infection in vivo. PLoS Pathog. 1:e10.
81. Ku B, Woo JS, Liang C, Lee KH, Hong HS, et al. 2008. Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine γ-herpesvirus 68. PLoS Pathog. 4:e25.
82. Xiaofei E, Hwang S, Oh S, Lee JS, Jeong JH, et al. 2009. Viral Bcl-2-mediated evasion of autophagy aids chronic infection of gammaherpesvirus 68. PLoS Pathog. 5:e1000609.
83. Virgin HW 4th, Presti RM, Li XY, Liu C, Speck SH. 1999. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infectedmice. J. Virol. 73:2321-32. (Pubitemid 29098137)
84. Marques S, Efstathiou S, Smith KG, Haury M, Simas JP. 2003. Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J. Virol. 77:7308-18. (Pubitemid 36734499)
85. Gangappa S, van Dyk LF, Jewett TJ, Speck SH, Virgin HW4th. 2002. Identification of the in vivo role of a viral bcl-2. J. Exp. Med. 195:931-40. (Pubitemid 34286763)
86. de Lima BD, May JS, Marques S, Simas JP, Stevenson PG. 2005. Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J. Gen. Virol. 86:31-40. (Pubitemid 40081148)
87. Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97:8051-56. (Pubitemid 30460771)
88. Ishido S, Choi JK, Lee BS, Wang C, DeMaria M, et al. 2000. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13:365-74.
89. Stevenson PG, Efstathiou S, Doherty PC, Lehner PJ. 2000. Inhibition ofMHCclass I-restricted antigen presentation by γ2-herpesviruses. Proc. Natl. Acad. Sci. USA 97:8455-60. (Pubitemid 30639694)
90. Cadwell K, Coscoy L. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309:127-30. (Pubitemid 40934990)
91. Cadwell K, Coscoy L. 2008. The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J. Virol. 82:4184-89. (Pubitemid 351521256)
92. Wang X, Herr RA, Chua WJ, Lybarger L, Wiertz EJ, Hansen TH. 2007. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177:613-24. (Pubitemid 46799833)
93. Yu YY, Harris MR, Lybarger L, Kimpler LA, Myers NB, et al. 2002. Physical association of the K3 protein of γ-2 herpesvirus 68 with major histocompatibility complex class I molecules with impaired peptide and β2-microglobulin assembly. J. Virol. 76:2796-803. (Pubitemid 34184866)
94. Lybarger L, Wang X, Harris MR, Virgin HW 4th, Hansen TH. 2003. Virus subversion of the MHC class I peptide-loading complex. Immunity 18:121-30. (Pubitemid 36120693)
95. Stevenson PG, May JS, Smith XG, Marques S, Adler H, et al. 2002. K3-mediated evasion of CD8+ T cells aids amplification of a latent γ-herpesvirus. Nat. Immunol. 3:733-40.
96. Stevenson PG, Boname JM, de Lima B, Efstathiou S. 2002. A battle for survival: immune control and immune evasion in murine γ-herpesvirus-68 infection. Microbes Infect. 4:1177-82. (Pubitemid 35279525)
97. Evans AG, Moorman NJ, Willer DO, Speck SH. 2006. The M4 gene of γHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency. Virology 344:520-31. (Pubitemid 43050945)
98. Simas JP, Swann D, Bowden R, Efstathiou S. 1999. Analysis ofmurine gammaherpesvirus-68 transcription during lytic and latent infection. J. Gen. Virol. 80(Pt. 1):75-82. (Pubitemid 29041683)
99. van Berkel V, Preiter K, Virgin HW4th, Speck SH. 1999. Identification and initial characterization of themurine gammaherpesvirus 68 geneM3, encoding an abundantly secreted protein. J. Virol. 73:4524-29. (Pubitemid 29189909)
100. van Berkel V, Barrett J, TiffanyHL, Fremont DH, Murphy PM, et al. 2000. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74:6741-47. (Pubitemid 30470656)
101. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, et al. 2000. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191:573-78.
102. Alexander JM, Nelson CA, van Berkel V, Lau EK, Studts JM, et al. 2002. Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111:343-56. (Pubitemid 35341389)
103. Bridgeman A, Stevenson PG, Simas JP, Efstathiou S. 2001. A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latent load. J. Exp. Med. 194:301-12. (Pubitemid 32730804)
104. Clambey ET, Virgin HW 4th, Speck SH. 2000. Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J. Virol. 74:1973-84. (Pubitemid 30434056)
105. Jacoby MA, VirginHW4th, Speck SH. 2002. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation. J. Virol. 76:1790-801. (Pubitemid 34094627)
106. van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HW 4th. 2002. Critical role for a high-affinity chemokine-binding protein in γ-herpesvirus-induced lethal meningitis. J. Clin. Investig. 109:905-14. (Pubitemid 34275111)
107. Evans AG, Moser JM, Krug LT, Pozharskaya V, Mora AL, Speck SH. 2008. A gammaherpesvirussecreted activator of Vβ4+ CD8+ T cells regulates chronic infection and immunopathology. J. Exp. Med. 205:669-84. (Pubitemid 351439312)
108. Mora AL, Torres-Gonźalez E, Rojas M, Xu J, Ritzenthaler J, et al. 2007. Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-γreceptor-deficient mice. Am. J. Respir. Crit. Care Med. 175:1139-50. (Pubitemid 46855455)
109. Coppola MA, Flano E, Nguyen P, Hardy CL, Cardin RD, et al. 1999. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection. J. Immunol. 163:1481-89. (Pubitemid 29352770)
110. Hardy CL, Flano E, Cardin RD, Kim IJ, Nguyen P, et al. 2001. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine γ-herpesvirus infection. Viral. Immunol. 14:391-402. (Pubitemid 34309067)
111. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. 2001. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15:579-89. (Pubitemid 33016443)
112. Tai AK, Luka J, Ablashi D, Huber BT. 2009. HHV-6A infection induces expression of HERV-K18- encoded superantigen. J. Clin. Virol. 46:47-48.
113. Yao Z, Maraskovsky E, Spriggs MK, Cohen JI, Armitage RJ, Alderson MR. 1996. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation. J. Immunol. 156:3260-66. (Pubitemid 26123540)
114. Duboise M, Guo J, Czajak S, Lee H, Veazey R, et al. 1998. A role for herpesvirus saimiri orf14 in transformation and persistent infection. J. Virol. 72:6770-76. (Pubitemid 28323996)
115. Husain SM, Usherwood EJ, Dyson H, Coleclough C, Coppola MA, et al. 1999. Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8+ T lymphocytes. Proc. Natl. Acad. Sci. USA 96:7508-13. (Pubitemid 29299692)
116. Herskowitz J, Jacoby MA, Speck SH. 2005. The murine gammaherpesvirus 68M2 gene is required for efficient reactivation from latently infected B cells. J. Virol. 79:2261-73. (Pubitemid 40204583)
117. Macrae AI, Usherwood EJ, Husain SM, Flano E, Kim IJ, et al. 2003. Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J. Virol. 77:9700-9. (Pubitemid 37011063)
118. Simas JP, Marques S, Bridgeman A, Efstathiou S, Adler H. 2004. The M2 gene product of murine gammaherpesvirus 68 is required for efficient colonization of splenic follicles but is not necessary for expansion of latently infected germinal centre B cells. J. Gen. Virol. 85:2789-97. (Pubitemid 39360021)
119. Herskowitz JH, Siegel AM, Jacoby MA, Speck SH. 2008. Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J. Virol. 82:3295-310. (Pubitemid 351429908)
120. Rodrigues L, Pires de Miranda M, Caloca MJ, Bustelo XR, Simas JP. 2006. Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes. J. Virol. 80:6123-35. (Pubitemid 43849190)
121. Madureira PA, Matos P, Soeiro I, Dixon LK, Simas JP, Lam EW. 2005. Murine γ-herpesvirus 68 latency proteinM2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells. J. Biol. Chem. 280:37310-18. (Pubitemid 41642336)
122. Pires deMiranda M, Alenquer M, Marques S, Rodrigues L, Lopes F, et al 2008. TheGammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS ONE 3, e1654.
123. Liang X, Pickering MT, Cho NH, Chang H, Volkert MR, et al. 2006. Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 80:5862-74. (Pubitemid 43849164)
124. Liang X, Shin YC, Means RE, Jung JU. 2004. Inhibition of interferon-mediated antiviral activity by murine gammaherpesvirus 68 latency-associated M2 protein. J. Virol. 78:12416-27. (Pubitemid 39458760)
125. Siegel AM, Herskowitz JH, Speck SH. 2008. The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog. 4:e1000039.
126. Collins CM, Boss JM, Speck SH. 2009. Identification of infected B-cell populations by using a recombinant murine gammaherpesvirus 68 expressing a fluorescent protein. J. Virol. 83:6484-93.
127. Liang X, Collins CM, Mendel JB, Iwakoshi NN, Speck SH. 2009. Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog. 5:e1000677.
128. Tibbetts SA, van Dyk LF, Speck SH, Virgin HW 4th. 2002. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J. Virol. 76:7125-32. (Pubitemid 41246226)
129. Stevenson PG, Simas JP, Efstathiou S. 2009. Immune control of mammalian γ-herpesviruses: lessons from murid herpesvirus-4. J. Gen. Virol. 90:2317-30.
130. BrittW. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325:417-70.
131. Flano E, Jia Q, Moore J, Woodland DL, Sun R, Blackman MA. 2005. Early establishment of γ- herpesvirus latency: implications for immune control. J. Immunol. 174:4972-78.
132. Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY. 2001. Dissecting the host response to a γ-herpesvirus. Philos. Trans. R. Soc. Lond. Ser. B 356:581-93.
133. Doherty PC, Riberdy JM, Belz GT. 2000. Quantitative analysis of the CD8+ T-cell response to readily eliminated and persistent viruses. Philos. Trans. R. Soc. Lond. Ser. B 355:1093-101.
134. Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, et al. 2003. Integration of interferon-α/βsignalling to p53 responses in tumour suppression and antiviral defence. Nature 424:516-23. (Pubitemid 36975769)
135. Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, et al. 2010. Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim. Biophys. Acta 1799:228-35.
136. Gray KS, Forrest JC, Speck SH. 2010. The de novo methyltransferases DNMT3a/3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J. Virol. 84:4946-59.
137. Gray KS, Allen RD 3rd, Farrell ML, Forrest JC, Speck SH. 2009. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency. J. Virol. 83:314-28.
138. Yang Z, Tang H, Huang H, Deng H. 2009. RTA promoter demethylation and histone acetylation regulation of murine gammaherpesvirus 68 reactivation. PLoS ONE 4:e4556.
139. G̈unther T, Grundhoff A. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935 39a.
140. Goodwin MM, Molleston JM, Canny S, Abou El Hassan M, Willert EK, et al. 2010. Histone deacetylases and the nuclear receptor corepressor regulate lytic-latent switch gene 50 in murine gammaherpesvirus 68-infected macrophages. J. Virol. 84:12039-47.
141. Bartek J, Bartkova J, Lukas J. 2007. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26:7773-79. (Pubitemid 350242463)
142. Sinclair A, Yarranton S, Schelcher C. 2006. DNA-damage response pathways triggered by viral replication. Expert Rev. Mol. Med. 8:1-11.
143. Tarakanova VL, Leung-Pineda V, Hwang S, Yang CW, Matatall K, et al. 2007. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-86. (Pubitemid 46865610)
144. Xie A, Scully R. 2007. Hijacking the DNA damage response to enhance viral replication: γ-herpesvirus 68 orf36 phosphorylates histone H2AX. Mol. Cell 27:178-79. (Pubitemid 47058313)
145. Forrest JC, Speck SH. 2008. Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of aDNAdamage-signaling cascade. J. Virol. 82:7688-99. (Pubitemid 352031234)
146. Tarakanova VL, Kreisel F, White DW, Virgin HW 4th. 2008. Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease. J. Virol. 82:1034-39.
147. Chen W, Hilton IB, Staudt MR, Burd CE, Dittmer DP. 2010. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma-associated Herpesvirus Lymphomas. J. Virol. 84:3898-908.
148. Lagunoff M, Carroll PA. 2003. Inhibition of apoptosis by the γ-herpesviruses. Int. Rev. Immunol. 22:373-99.
149. Feng P, Liang C, Shin YC, Xiaofei E, Zhang W, et al. 2007. A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein. PLoS Pathog. 3:e174.
150. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HW 4th. 2005. Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79:661-67. (Pubitemid 39648423)
151. Bortoluci KR, Medzhitov R. 2010. Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol. Life Sci. 67:1643-51.
152. Taylor GS, Rickinson AB. 2007. Antigens and autophagy: the path less travelled? Autophagy 3:60-62. (Pubitemid 46100717)
153. Sinha S, Colbert CL, Becker N, Wei Y, Levine B. 2008. Molecular basis of the regulation of Beclin 1-dependent autophagy by the γ-herpesvirus 68 Bcl-2 homolog M11. Autophagy 4:989-97.
154. Watts C, West MA, Zaru R. 2010. TLR signalling regulated antigen presentation in dendritic cells. Curr. Opin. Immunol. 22:124-30.
155. Krug LT, Collins CM, Gargano LM, Speck SH. 2009. NF-κB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J. Virol. 83:4732-48.
156. Krug LT, Moser JM, Dickerson SM, Speck SH. 2007. Inhibition of NF-κB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog. 3:e11.
157. Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R. 2003. NF-κB inhibits gammaherpesvirus lytic replication. J. Virol. 77:8532-40. (Pubitemid 36871481)
158. Rodrigues L, Filipe J, Seldon MP, Fonseca L, Anrather J, et al. 2009. Termination of NF-κB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J. 28:1283-95.
159. Goetz CA, Baldwin AS. 2008. NF-κB pathways in the immune system: control of the germinal center reaction. Immunol. Res. 41:233-47.
160. Pasare C, Medzhitov R. 2005. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560:11-18.
161. Guggemoos S, Hangel D, Hamm S, Heit A, Bauer S, Adler H. 2008. TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J. Immunol. 180:438-43.
162. Gargano LM, Moser JM, Speck SH. 2008. Role forMyD88 signaling in murine gammaherpesvirus 68 latency. J. Virol. 82:3853-63. (Pubitemid 351521222)
163. Pasare C, Medzhitov R. 2005. Control of B-cell responses by Toll-like receptors. Nature 438:364-68. (Pubitemid 41643953)
164. Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B. 2009. Toll-like receptor signaling controls reactivation of KSHV from latency. Proc. Natl. Acad. Sci. USA 106:11725-30.
165. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535-84. (Pubitemid 351600385)
166. Wies E, Hahn AS, Schmidt K, Viebahn C, Rohland N, et al. 2009. The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5. J. Biol. Chem. 284:8525-38.
167. Offermann MK. 2007. Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr. Top. Microbiol. Immunol. 312:185-209. (Pubitemid 47400348)
168. Hahn AM, Huye LE, Ning S, Webster-Cyriaque J, Pagano JS. 2005. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J. Virol. 79:10040-52. (Pubitemid 41022345)
169. Hwang S, KimKS, Flano E, Wu TT, Tong LM, et al. 2009. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host. Microbe 5:166-78.
170. Wang JT, Doong SL, Teng SC, Lee CP, Tsai CH, Chen MR. 2009. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J. Virol. 83:1856-69.
171. Zhu FX, King SM, Smith EJ, Levy DE, YuanY. 2002.AKaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc. Natl. Acad. Sci. USA 99:5573-78. (Pubitemid 34411590)
172. Ning S, Huye LE, Pagano JS. 2005. Interferon regulatory factor 5 represses expression of the Epstein- Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J. Virol. 79:11671-76. (Pubitemid 41279285)
173. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432-35. (Pubitemid 35346145)
174. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307-36.
175. Barton ES, Lutzke ML, Rochford R, Virgin HW 4th. 2005. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J. Virol. 79:14149-60. (Pubitemid 41552713)
176. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA 104:1371-76. (Pubitemid 46184011)
177. Weslow-Schmidt JL, Jewell NA, Mertz SE, Simas JP, Durbin JE, Flano E. 2007. Type I interferon inhibition and dendritic cell activation during gammaherpesvirus respiratory infection. J. Virol. 81:9778-89. (Pubitemid 350067682)
178. Gresser I, Vignaux F, Belardelli F, Tovey MG, MaunouryMT. 1985. Injection ofmice with antibody to mouse interferon α/βdecreases the level of 2-5- oligoadenylate synthetase in peritoneal macrophages. J. Virol. 53:221-27.
179. Kim PS, Ahmed R. 2010. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22:223-30.
180. Freeman ML, Lanzer KG, Cookenham T, Peters B, Sidney J, et al. 2010. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection. J. Virol. 84:2881-92.
181. Gredmark-Russ S, Cheung EJ, Isaacson MK, Ploegh HL, Grotenbreg GM. 2008. The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 82:12205-12.
182. Liu L, Flano E, Usherwood EJ, Surman S, Blackman MA, Woodland DL. 1999. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection. J. Immunol. 163:868-74. (Pubitemid 29328096)
183. Stevenson PG, Belz GT, Altman JD, Doherty PC. 1999. Changing patterns of dominance in the CD8+ Tcell response during acute and persistentmurineγ- herpesvirus infection. Eur. J. Immunol. 29:1059-67. (Pubitemid 29164150)
184. Cush SS, Anderson KM, Ravneberg DH, Weslow-Schmidt JL, Flano E. 2007. Memory generation and maintenance of CD8+ T cell function during viral persistence. J. Immunol. 179:141-53. (Pubitemid 46986528)
185. Cush SS, Flano E. 2009. Protective antigen-independent CD8 T cell memory is maintained during γ-herpesvirus persistence. J. Immunol. 182:3995-4004.
186. Zhang W, Zhang T, Turk MJ, Usherwood EJ. 2010. A persistent virus vector confers superior antitumor immunity, compared with a non-persistent vector. Cancer Immunol. Immunother. 59:707-13.
187. Obar JJ, Crist SG, Gondek DC, Usherwood EJ. 2004. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection. J. Immunol. 172:1213-19. (Pubitemid 38113784)
188. Marques S, Alenquer M, Stevenson PG, Simas JP. 2008.AsingleCD8+ Tcell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog. 4:e1000177.
189. Bennett NJ, May JS, Stevenson PG. 2005. Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol. 3:e120.
190. Flano E, Woodland DL, Blackman MA, Doherty PC. 2001. Analysis of virus-specific CD4+ T cells during long-term gammaherpesvirus infection. J. Virol. 75:7744-48. (Pubitemid 32738035)
191. VirginHW, Speck SH. 1999. Unraveling immunity to γ-herpesviruses: a newmodel for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-79. (Pubitemid 29377902)
192. Cardin RD, Brooks JW, Sarawar SR, Doherty PC. 1996. Progressive loss of CD8+ T cell-mediated control of a γ-herpesvirus in the absence of CD4+ T cells. J. Exp. Med. 184:863-71.
193. Lee KS, Cool CD, van Dyk LF. 2009. Murine gammaherpesvirus 68 infection of gamma interferondeficient mice on a BALB/c background results in acute lethal pneumonia that is dependent on specific viral genes. J. Virol. 83:11397-401.
194. Topham DJ, Cardin RC, Christensen JP, Brooks JW, Belz GT, Doherty PC. 2001. Perforin and Fas in murine gammaherpesvirus-specific CD8+ T cell control and morbidity. J. Gen. Virol. 82:1971-81. (Pubitemid 32707563)
195. Mueller N. 1987. Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. Yale J. Biol. Med. 60:321-32.
196. Loh J, Thomas DA, Revell PA, Ley TJ, VirginHW4th. 2004. Granzymes and caspase 3 play important roles in control of gammaherpesvirus latency. J. Virol. 78:12519-28. (Pubitemid 39458770)
197. Braaten DC, McClellan JS, Messaoudi I, Tibbetts SA, McClellan KB, et al. 2006. Effective control of chronic γ-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells. PLoS Pathog. 2:e37.
198. Christensen JP, Cardin RD, Branum KC, Doherty PC. 1999. CD4+ T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proc. Natl. Acad. Sci. USA 96:5135-40. (Pubitemid 29214548)
199. Sparks-Thissen RL, Braaten DC, Hildner K, Murphy TL, Murphy KM, Virgin HW4th. 2005. CD4 T cell control of acute and latentmurine gammaherpesvirus infection requires IFNγ. Virology 338:201-8. (Pubitemid 41019189)
200. Sparks-Thissen RL, Braaten DC, Kreher S, Speck SH, VirginHW4th. 2004. An optimizedCD4 T-cell response can control productive and latent gammaherpesvirus infection. J. Virol. 78:6827-35. (Pubitemid 38781520)
201. Stuller KA, Cush SS, Flano E. 2010. Persistent γ-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations. J. Immunol. 184:3850-56.
202. Steed A, Buch T, Waisman A, Virgin HW 4th. 2007. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner. J. Virol. 81:6134-40. (Pubitemid 46847051)
203. Steed AL, Barton ES, Tibbetts SA, Popkin DL, Lutzke ML, et al. 2006. Gamma interferon blocks gammaherpesvirus reactivation from latency. J. Virol. 80:192-200.
204. Goodwin MM, Canny S, Steed A, VirginHW. 2010. Murine gammaherpesvirus 68 has evolved gamma interferon and stat1-repressible promoters for the lytic switch gene 50. J. Virol. 84:3711-17.
205. Badovinac VP, Tvinnereim AR, Harty JT. 2000. Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-γ. Science 290:1354-58.
206. Whitmire JK, Eam B, Benning N, Whitton JL. 2007. Direct interferon-γsignaling dramatically enhances CD4+ and CD8+ T cell memory. J. Immunol. 179:1190-97.
207. Ridge JP, Di Rosa F, Matzinger P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474-78.
208. Giannoni F, Shea A, Inglis C, Lee LN, Sarawar SR. 2008. CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68. J. Virol. 82:11016-22.
209. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. 2006. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J. Exp. Med. 203:2223-27. (Pubitemid 44498355)
210. Dias P, Giannoni F, Lee LN, Han D, Yoon S, et al. 2010. CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1- PD-L1 interactions. J. Virol. 84:8241-49.
211. Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852-56. (Pubitemid 36254145)
212. Khanolkar A, Badovinac VP, Harty JT. 2007. CD8 T cell memory development: CD4 T cell help is appreciated. Immunol. Res. 39:94-104. (Pubitemid 47574900)
213. Stevenson PG, Doherty PC. 1998. Kinetic analysis of the specific host response to a murine gammaherpesvirus. J. Virol. 72:943-49. (Pubitemid 28116871)
214. Sangster MY, Topham DJ, D'Costa S, Cardin RD, Marion TN, et al. 2000. Analysis of the virusspecific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J. Immunol. 164:1820-28. (Pubitemid 30108735)
215. Rosa GT, Gillet L, SmithCM, deLimaBD, Stevenson PG. 2007. IgG fc receptors provide an alternative infection route for murine γ-herpesvirus- 68. PLoS ONE 2:e560.
216. Tibbetts SA, McClellan JS, Gangappa S, Speck SH, VirginHW4th. 2003. Effective vaccination against long-term gammaherpesvirus latency. J. Virol. 77:2522-29. (Pubitemid 36222776)
217. Kim IJ, Flano E, Woodland DL, Blackman MA. 2002. Antibody-mediated control of persistent γ- herpesvirus infection. J. Immunol. 168:3958-64. (Pubitemid 34298400)
218. Gangappa S, Kapadia SB, Speck SH, Virgin HW 4th. 2002. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J. Virol. 76:11460-68. (Pubitemid 35231302)
219. McClellan KB, Gangappa S, Speck SH, Virgin HW 4th. 2006. Antibody-independent control of γ- herpesvirus latency via B cell induction of anti-viral T cell responses. PLoS Pathog. 2:e58.
220. Posnett DN. 2008. Herpesviruses and autoimmunity. Curr. Opin. Investig. Drugs 9:505-14. (Pubitemid 351677905)
221. Peacock JW, Elsawa SF, Petty CC, Hickey WF, Bost KL. 2003. Exacerbation of experimental autoimmune encephalomyelitis in rodents infected with murine gammaherpesvirus-68. Eur. J. Immunol. 33:1849-58. (Pubitemid 37120856)
222. McMillan TR, Moore BB, Weinberg JB, Vannella KM, Fields WB, et al. 2008. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am. J. Respir. Crit. Care Med. 177:771-80. (Pubitemid 351490564)
223. Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. 2000. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102:779-85. (Pubitemid 30648767)
224. Alber DG, Vallance P, Powell KL. 2002. Enhanced atherogenesis is not an obligatory response to systemic herpesvirus infection in the apoE-deficient mouse: comparison of murine γ-herpesvirus-68 and herpes simplex virus-1. Arterioscler. Thromb. Vasc. Biol. 22:793-98. (Pubitemid 34517791)
225. Nelson DA, Petty CC, Bost KL. 2009. Infection withmurine gammaherpesvirus 68 exacerbates inflammatory bowel disease in IL-10-deficient mice. Inflamm. Res. 58:881-89.
226. Smith KA, Efstathiou S, Cooke A. 2007. Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J. Immunol. 179:7325-33.
227. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, et al. 2010. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-45.
228. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, et al. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326-29. (Pubitemid 46788830)
229. Haque A, Rachinel N, Quddus MR, Haque S, Kasper LH, Usherwood E. 2004. Co-infection of malaria and γ-herpesvirus: exacerbated lung inflammation or cross-protection depends on the stage of viral infection. Clin. Exp. Immunol. 138:396-404. (Pubitemid 39573617)
230. Nguyen Y, McGuffie BA, Anderson VE, Weinberg JB. 2008. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380:182-90.
231. Saghafian-Hedengren S, Sverremark-Ekstr̈om E, Linde A, Lilja G, Nilsson C. 2010. Early-life EBV infection protects against persistent IgE sensitization. J. Allergy Clin. Immunol. 125:433-38.
232. Pyzik M, Kielczewska A, Vidal SM. 2008. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin. Immunol. 20:331-42.
233. Usherwood EJ, Meadows SK, Crist SG, Bellfy SC, Sentman CL. 2005. Control of murine gammaherpesvirus infection is independent of NK cells. Eur. J. Immunol. 35:2956-61. (Pubitemid 41555091)
234. Thomson RC, Petrik J, Nash AA, Dutia BM. 2008. Expansion and activation of NK cell populations in a gammaherpesvirus infection. Scand. J. Immunol. 67:489-95. (Pubitemid 351519398)
235. White DW, Keppel CR, Schneider SE, Reese TA, Coder J, et al. 2010. Latent herpesvirus infection arms NK cells. Blood 115:4377-83.
236. Virgin HW, Wherry EJ, Ahmed R. 2009. Redefining chronic viral infection. Cell 138:30-50.
237. Kapadia SB, Levine B, Speck SH, Virgin HW. 2002. Critical role of complement and viral evasion of complement in acute, persistent and latency γ-herpesvirus infection. Immunity 17:143-55. (Pubitemid 35245957)
238. Pavlova IV, Virgin HW, Speck SH. 2003. Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication. J. Virol. 77:5731-39. (Pubitemid 36538966)
239. Moser JM, Farrell ML, Krug LT, Upton JW, Speck SH. 2006. A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against awild-type virus challenge. J Virol. 80:1592-98 (Pubitemid 43134115)